Severe outcomes of COVID-19 among adults with increased risk conditions: A population-based observational study
PLOS ONE · 11.02.2025 · 20 (2) · e0316529
DOI: 10.1371/journal.pone.0316529 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift PLOS ONE, online erschienen am 11.02.2025. Verfasst von Scott Dryden-Peterson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Brigham and Women's Hospital, Boston, Massachusetts, United States of America. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, Office of AIDS Research.
Abstract (Originalsprache)
Background
The individual risk of severe outcomes following COVID-19 is poorly understood in populations with prior immunity. The lack of contemporary estimates limits support of timely diagnosis and antiviral treatment for individuals most likely to benefit.
Objective
To determine the risk of severe outcomes following COVID-19 within strata of comorbidities, including patients without documented infection.
Design
Population-based cohort study utilizing electronic medical records and g methods to account for selection bias in the documentation of COVID-19 illnesses.
Setting
A large health system in northeastern United States Patients Adults with increased risk conditions (90% vaccinated) and COVID-19 from June to December 2022.
Measurements
Incidence of composite of inpatient admission within 14 days and death within 28 days of COVID-19 diagnosis.
Results
An estimated 265,248 patients with at least one increased risk condition developed COVID-19, including 76,996 documented cases. Severe outcomes occurred in 3344 (1.3%) patients following COVID-19— 3147 (1.2%) hospitalizations and 376 (0.14%) deaths. In the absence of treatment, individuals with few increased risk conditions (MASS of 3 or less) accounted for 57% of infections and 0.7% developed severe outcomes. In contrast, 2.3% of patients with multiple increased risk conditions (MASS 4 or greater) or severe immunocompromise experienced severe outcomes, including 81% of deaths. The observed risk reduction with antiviral treatment was -0.1% (-0.2 to 0.02%), -0.6% (-0.9 to -0.4%), -1.3% (-2 to -1%), and -1.9% (-3 to -1%) for patients with MASS 3 or less, MASS 4 and 5, MASS 6 or greater, and severe immunocompromise, respectively.
Limitations
Estimated number COVID-19 cases cannot be directly verified Conclusions Individuals with multiple medical conditions remain at substantial risk for severe outcomes of COVID-19 and benefit from treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
- Mass General Brigham, Somerville, Massachusetts, United States of America.
- Harvard Medical School, Boston, Massachusetts, United States of America.
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
- Massachusetts General Hospital, Boston, Massachusetts, United States of America.
- Mass General Brigham Community Physicians, Somerville, Massachusetts, United States of America.
ORCID-Profile: Scott Dryden-Peterson, David Rubins
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- Office of AIDS Research
- National Cancer Institute
Zitieren
APA
Dryden-Peterson, S., Kim, A., Caniglia, E. C., Joyce, M. R., Rubins, D., Kim, A. Y., Fangman, J., Baden, L. R., & Woolley, A. E. (2025). Severe outcomes of COVID-19 among adults with increased risk conditions: A population-based observational study. PLOS ONE, 20(2), e0316529. https://doi.org/10.1371/journal.pone.0316529
Vancouver
Dryden-Peterson S, Kim A, Caniglia EC, Joyce MR, Rubins D, Kim AY, et al. Severe outcomes of COVID-19 among adults with increased risk conditions: A population-based observational study. PLOS ONE. 2025;20(2):e0316529. doi:10.1371/journal.pone.0316529
BibTeX
@article{DrydenPeterson2025,
author = {Dryden-Peterson, Scott and Kim, Andy and Caniglia, Ellen C and Joyce, Mary-Ruth and Rubins, David and Kim, Arthur Y and Fangman, John and Baden, Lindsey R and Woolley, Ann E},
title = {Severe outcomes of COVID-19 among adults with increased risk conditions: A population-based observational study},
journal = {PLOS ONE},
year = {2025},
volume = {20},
number = {2},
pages = {e0316529},
doi = {10.1371/journal.pone.0316529}
}
EUVIMED